Versarien, an advanced materials group that creates innovative engineering solutions in a diverse range of industries, announced the participation of the Company's subsidiary, 2-DTech, in a new project funded by EPSRC (the UK's main agency for funding research in engineering and the physical sciences). The project 2D Materials for Next Generation Healthcare Technologies (2D-Health) started on October 1st and will utilize £5.2 million of funding over the next 5 years.
The project, in which Graphenea also recently announced its participation, is one of four major research grants awarded as part of the EPSRC Healthcare Technologies scheme, that will develop new technologies to address the health issues of an aging UK population. 2D-Health will aim to utilize the unique properties offered by graphene to develop innovative solutions for specific unmet clinical needs, particularly in wound care and management (relevant to diabetes), tissue rehabilitation by electrical stimulation (relevant to dementia), cell therapeutics (relevant to cardiovascular disease), and immunotherapeutics (relevant to cancer).